{"id":"musk-pill","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dry mouth"},{"rate":"5-10%","effect":"Blurred vision"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking this receptor, MUSK pill reduces the symptoms of certain conditions, such as excessive salivation and sweating. This is achieved through a complex process involving the regulation of the autonomic nervous system. The exact mechanisms are not fully understood.","oneSentence":"MUSK pill works by inhibiting the activity of the muscarinic acetylcholine receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:56:19.714Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of glaucoma"}]},"trialDetails":[{"nctId":"NCT05095922","phase":"PHASE4","title":"Effect of HMP on Diabetic Microangiopaemia in T2DM","status":"COMPLETED","sponsor":"Affiliated Hospital of Nantong University","startDate":"2023-03-28","conditions":"Diabetes Mellitus, Type 2, Diabetic Angiopathies","enrollment":40},{"nctId":"NCT04897126","phase":"PHASE4","title":"Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery","status":"COMPLETED","sponsor":"Shanghai Hutchison Pharmaceuticals Limited","startDate":"2021-05-11","conditions":"Ischemia With Non-Obstructive Coronary Artery, Angina Pectoris, Coronary Heart Disease","enrollment":240},{"nctId":"NCT04984954","phase":"PHASE4","title":"Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction","status":"UNKNOWN","sponsor":"Shanghai Hutchison Pharmaceuticals Limited","startDate":"2021-01-28","conditions":"Angina Pectoris, Coronary Heart Disease, X Syndrome, Angina","enrollment":264},{"nctId":"NCT03219515","phase":"NA","title":"Herbal Medication (Gongjin-dan) for Chronic Dizziness","status":"UNKNOWN","sponsor":"Kyunghee University","startDate":"2018-04-01","conditions":"Dizziness Chronic","enrollment":78},{"nctId":"NCT01897805","phase":"PHASE4","title":"A Trial to Evaluate Efficacy of Heart-protecting Musk Pill","status":"UNKNOWN","sponsor":"Shanghai Hutchison Pharmaceuticals Limited","startDate":"2011-07","conditions":"Coronary Artery Disease","enrollment":2700}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"marketed","status":"active","brandName":"MUSK pill","genericName":"MUSK pill","companyName":"Shanghai Hutchison Pharmaceuticals Limited","companyId":"shanghai-hutchison-pharmaceuticals-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"The MUSK pill is a small molecule being studied in a clinical trial for its potential efficacy and safety in treating coronary microvascular dysfunction, which is associated with conditions such as coronary heart disease and angina pectoris. The trial, registered on ClinicalTrials.gov as NCT04984954, is a multicenter, randomized, double-blind, placebo-controlled study evaluating the MUSK pill's effects on coronary microvascular dysfunction.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}